3billion, Inc. (KOSDAQ:394800)
South Korea · Delayed Price · Currency is KRW 4,300.00
-100.00 (-2.27%)
At close: Sep 11, 2026
3billion Revenue
In the year 2025, 3billion had annual revenue of 11.71B KRW with 102.85% growth. 3billion had revenue of 3.88B in the quarter ending December 31, 2025, with 98.33% growth.
Revenue
11.71B
Revenue Growth
+102.85%
P/S Ratio
11.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
136.84B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.71B | 5.94B | 102.85% |
| Dec 31, 2024 | 5.77B | 3.04B | 111.41% |
| Dec 31, 2023 | 2.73B | 1.90B | 229.57% |
| Dec 31, 2022 | 828.46M | 277.80M | 50.45% |
| Dec 31, 2021 | 550.66M | 525.57M | 2,095.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GC Medical Science | 102.16B |
| Seoulin Bioscience | 83.17B |
| Cytogen | 27.38B |
| Dx & Vx | 26.22B |
| Protia | 17.75B |
| HLB Panagene | 14.71B |
| GENINUS | 11.28B |
| Median Diagnostics | 7.86B |